Evaluation of an Integrated, Digital, Nurse-led, Remote Monitoring Care Pathway for Cardiovascular Risk Management
NCT ID: NCT07208331
Last Updated: 2025-10-06
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
NOT_YET_RECRUITING
750 participants
OBSERVATIONAL
2025-10-06
2030-10-01
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Continuous Monitoring of Patients in and After the Acute Admission Ward to Optimize Clinical Pathways
NCT05181111
Closed-Loop Titration of Vasopressor Infusions: Feasibility Study or Proof of Concept Study
NCT03515161
Influence of Telemonitoring on the Management of LVAD-patients
NCT04613401
Patient Perspective on Remote Monitoring of Cardiovascular Implantable Electronic Devices
NCT01691586
Cardiovascular Precision Medicine & Remote Intervention
NCT05814562
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
A digital care pathway may improve therapy adherence and outcomes by enabling personalized, data-driven care. This study evaluates the effectiveness of a nurse-led, telemonitoring pathway for CVRM in routine practice, where patients measure their blood pressure and LDL-c levels at home. The study aims to improve risk stratification, support earlier intervention, and optimize lipid and blood pressure control, ultimately leading to better patient outcomes.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
COHORT
PROSPECTIVE
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* All patients enrolled in the program (high-risk and very high-risk patients)
Exclusion Criteria
* No access to smartphone and/or tablet
* Inability to use digital tools required for the program
18 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Cardiology Centres of the Netherlands
UNKNOWN
Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA)
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
M.M. Winter
MD, PhD
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Cardiology Centers of the Netherlands (CCN)
Amsterdam, North Holland, Netherlands
Countries
Review the countries where the study has at least one active or historical site.
Central Contacts
Reach out to these primary contacts for questions about participation or study logistics.
Facility Contacts
Find local site contact details for specific facilities participating in the trial.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
2025.0543
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.